NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled
NCT05226871 2025-11-25Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesPfizerPhase 2 Active not recruiting35 enrolled